1. (1) The Facility shall develop pharmacotherapy guidelines for service recipients covering the Facility’s own prescribing and the review of prescriptions from other providers. These shall minimally include:

   1. (a) Procedures to ensure that service recipients’ prescriptions from outside providers will be reported to the medical staff and reviewed by the program provider at admission and annually thereafter;
   2. (b) Procedures describing the Facility’s response when information about prescriptions from outside providers is not reported including, but not limited to, the loss of take- home privileges, to ensure compliance with this rule; and
   3. (c) If a Facility is unable to acquire information about a service recipient’s prescriptions, the Facility shall document efforts made to obtain information about prescriptions from outside providers or pharmacies in the service recipient’s medical record.

2. (2) The Facility shall query the PMP when clinically indicated at the program provider’s discretion and at a minimum:

   1. (a) Upon admission of a service recipient; and
   2. (b) Every three (3) months for the first one (1) year of treatment, and every six (6) months thereafter. The service recipient’s medical record shall include documentation of the OPIOD TREATMENT PROGRAM FACILITIES check of the PMP database, the date upon which it occurred, the results of the PMP check, and any follow-up actions from the results. If the PMP report yields a result that the service recipient is receiving other controlled prescription medication(s), appropriate documentation of the prescription(s) must be in the service recipient’s medical record.

Authority: T.C.A. §§ 4-3-1601, 4-4-103, 33-1-302, 33-1-305, 33-1-309, 33-2-302, and 33-2-404. Administrative History: Original rule filed September 20, 2012; effective December 19, 2012. Amendments filed June 6, 2025; effective September 4, 2025.